Page 80 - Broadridge Distributed Ledger Repo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Broadridge distributed ledger repo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Broadridge Distributed Ledger Repo Today - Breaking & Trending Today

Gyroscope Therapeutics Holdings plc: Gyroscope Therapeutics Postpones Initial Public Offering

Gyroscope Therapeutics Holdings plc: Gyroscope Therapeutics Postpones Initial Public Offering
Gyroscope Therapeutics Holdings plc ( Gyroscope ), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced it has postponed plans for its initial public offering.
In light of market conditions, we have decided to postpone our planned initial public offering, said Khurem Farooq, Chief Executive Officer. Based on the positive feedback we have received from institutional investors on the strength of our science and investigational gene therapies, we believe it s in the best interest of our existing shareholders and employees to execute our IPO in more favorable market conditions. In the meantime, we are continuing to advance our clinical program for our investigational gene therapy, GT005, as well as our earlier stage pipeline. ....

New York , United States , United Kingdom , City Of , San Francisco , Charlotte Arnold , Kostenloser Wertpapierhandel , Khurem Farooq , Broadridge Financial Solutions , Drug Administration , Financial Services , Gyroscope Therapeutics Holdings , Exchange Commission , Prospectus Department , European Union , Goldman Sachs Co , Citigroup Global Markets Inc , Morgan Stanley Co , Corporate Affairs , Chief Executive , Fast Track , European Economic Area , Qualified Investors , Markets Act , Financial Promotion , Morgan Stanley ,

Gyroscope Therapeutics Postpones Initial Public Offering

Press release content from Business Wire. The AP news staff was not involved in its creation.
Gyroscope Therapeutics Postpones Initial Public Offering
May 7, 2021 GMT
LONDON (BUSINESS WIRE) May 7, 2021
Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced it has postponed plans for its initial public offering.
“In light of market conditions, we have decided to postpone our planned initial public offering,” said Khurem Farooq, Chief Executive Officer. “Based on the positive feedback we have received from institutional investors on the strength of our science and investigational gene therapies, we believe it’s in the best interest of our existing shareholders and employees to execute our IPO in more favorable market conditions. In the meantime, we are continuing to advance our clinical program for our investigational gene therapy, GT005, as well as our earlier ....

New York , United States , United Kingdom , City Of , San Francisco , Charlotte Arnold , Khurem Farooq , Broadridge Financial Solutions , Drug Administration , Gyroscope Therapeutics Holdings , Financial Services , Exchange Commission , Prospectus Department , European Union , Goldman Sachs Co , Citigroup Global Markets Inc , Morgan Stanley Co , Corporate Affairs , Therapeutics Holdings , Chief Executive , Fast Track , European Economic Area , Qualified Investors , Markets Act , Financial Promotion , Morgan Stanley ,

Investegate |Syncona Limited Announcements | Syncona Limited: Gyroscope Therapeutics update on proposed IPO

Tel: +44 (0) 20 3727 1000

About Syncona
Syncona s purpose is to invest to extend and enhance human life. We do this by founding, building and funding a portfolio of global leaders in life science, to deliver transformational treatments to patients in areas of high unmet need.

Our strategy is to found, build and fund companies around exceptional science to create a dynamic portfolio of 15-20 globally leading healthcare businesses for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our strategic balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or few treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders. ....

New York , United States , United Kingdom , City Of , San Francisco , Charlotte Arnold , Collins Tim Stamper , Khurem Farooq , Annabel Clay , Ben Atwell Natalie , Broadridge Financial Solutions , Syncona Ltd Is Andrew Cossar , Drug Administration , Gyroscope Therapeutics Holdings , Financial Services , Exchange Commission , Prospectus Department , European Union , Goldman Sachs Co , Syncona Ltd , Citigroup Global Markets Inc , Morgan Stanley Co , Corporate Affairs , Market Abuse Regulation , Andrew Cossar , General Counsel ,

Gyroscope Therapeutics Announces Launch of Initial Public Offering

Published: May 03, 2021

LONDON (BUSINESS WIRE) Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced that it has launched the roadshow for its initial public offering in the United States of up to 6,750,000 American Depositary Shares (“ADSs”) representing 6,750,000 ordinary shares. The initial public offering price is currently expected to be between $20.00 and $22.00 per ADS, which would result in an approximate total offering size of between $135.0 million and $148.5 million, before underwriting discounts and commissions. Gyroscope also expects to grant to the underwriters a 30-day option to purchase up to an additional 1,012,500 ADSs at the initial public offering price, less underwriting discounts and commissions. All ADSs to be sold in the proposed offering will be sold by Gyroscope. Gyroscope has applied to list its ADSs on the Nasdaq Global Select Mark ....

New York , United States , United Kingdom , City Of , San Francisco , Morgan Stanley , Broadridge Financial Solutions , Drug Administration , Gyroscope Therapeutics Holdings , Financial Services , Exchange Commission , Prospectus Department , European Union , Goldman Sachs Co , Citigroup Global Markets Inc , Morgan Stanley Co , Therapeutics Holdings , Depositary Shares , Nasdaq Global Select Market , Goldman Sachs , Island Avenue , European Economic Area , Qualified Investors , Markets Act , Financial Promotion , Fast Track ,

RBA shifts focus to July meeting

Asia Market Update: Modest equity moves seen in Asia amid continuing holidays and mixed US session; USD index rises after prior drop; RBA shifts focus ....

United States , New Zealand , Hong Kong , Ted Obrien , Henry Schein , Sabre Corp , Thomson Reuters , Martin Marietta Materials , Marathon Petroleum , Warner Music Group , Eaton Corp , Bausch Health , Asia Market Update , Financial Stability Report , Apollo Global , Berry Global , Broadridge Financial , Charles River Labs , Corsair Gaming , Global Payments , Lamar Advertising , Sealed Air , Under Armour , Vulcan Materials , Westlake Chemical , New Zealand Fin Min Robertson ,